If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Bossi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles
Head and Neck Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Stomatitis Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

1 Citation (Scopus)

A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes

De Cecco, L., Serafini, M. S., Facco, C., Granata, R., Orlandi, E., Fallai, C., Licitra, L., Marchesi, E., Perrone, F., Pilotti, S., Quattrone, P., Piazza, C., Sessa, F., Turri-Zanoni, M., Battaglia, P., Castelnuovo, P., Antognoni, P., Canevari, S. & Bossi, P., Mar 2019, In : Oral Oncology. 90, p. 94-101 8 p.

Research output: Contribution to journalArticle

Open Access
Gene Expression
Neoplasms
Squamous Cell Carcinoma
Neoplasm Genes
Discriminant Analysis

A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy

Zini, E. M., Lanzola, G., Quaglini, S., Bossi, P., Licitra, L. & Resteghini, C., Sep 2019, In : International Journal of Medical Informatics. 129, p. 404-412 9 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Radiotherapy
Smartphone
Neck
Head

Cetuximab in the management of nasopharyngeal carcinoma - A narrative review

Iqbal, M. S., Wilkinson, D., Tin, A., Bossi, P., Gradwell-Nelson, L., Kovarik, J., O'Hara, J. & Kelly, C., Jan 1 2019, (Accepted/In press) In : Journal of Laryngology and Otology.

Research output: Contribution to journalReview article

Nasopharyngeal Neoplasms
Induction Chemotherapy
Chemoradiotherapy
Cetuximab
Nasopharyngeal carcinoma

Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting

Depenni, R., Cossu Rocca, M., Ferrari, D., Azzarello, G., Baldessari, C., Alù, M., Nolé, F., Codecà, C., Boscolo, G., Piccininni, M., Cavalieri, S. & Bossi, P., Jul 2019, In : European Journal of Cancer. 115, p. 4-12 9 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Platinum
Residual Neoplasm
Drug Therapy
Disease-Free Survival

Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck Cancer

Rognoni, C., Quaglini, S., Vermorken, J. B., De Cecco, L., Licitra, L. & Bossi, P., Jan 1 2019, (Accepted/In press) In : Clinical Therapeutics.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Platinum
Patient Selection
Cost-Benefit Analysis
Fluorouracil